{"id":55186,"date":"2023-03-25T01:03:16","date_gmt":"2023-03-25T00:03:16","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/gordon-moore-intel-co-founder-dies-at-94\/"},"modified":"2023-03-25T01:03:16","modified_gmt":"2023-03-25T00:03:16","slug":"gordon-moore-intel-co-founder-dies-at-94","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/gordon-moore-intel-co-founder-dies-at-94\/","title":{"rendered":"Gordon Moore, Intel Co-Founder, Dies at 94"},"content":{"rendered":"<div>\n<p class=\"bwalignc\">\n<b>Moore, who set the course for the future of the semiconductor industry, devoted his later years to philanthropy.<\/b>\n<\/p>\n<p>SANTA CLARA, Calif.&#8211;(BUSINESS WIRE)&#8211;Intel and the Gordon and Betty Moore Foundation announced today that company co-founder Gordon Moore has passed away at the age of 94.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230324005411\/en\/1747445\/5\/gordon-moore-6-rwd.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230324005411\/en\/1747445\/21\/gordon-moore-6-rwd.jpg\"><\/a><br \/><a href=\"https:\/\/mms.businesswire.com\/media\/20230324005411\/en\/817781\/5\/intel_logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230324005411\/en\/817781\/21\/intel_logo.jpg\"><\/a><\/p>\n<p>\nThe foundation reported he died peacefully on Friday, March 24, 2023, surrounded by family at his home in Hawaii.\n<\/p>\n<p>\nMoore and his longtime colleague Robert Noyce founded Intel in July 1968. Moore initially served as executive vice president until 1975, when he became president. In 1979, Moore was named chairman of the board and chief executive officer, posts he held until 1987, when he gave up the CEO position and continued as chairman. In 1997, Moore became chairman emeritus, stepping down in 2006.\n<\/p>\n<p>\n<b>More:<\/b> <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.intel.com%2Fcontent%2Fwww%2Fus%2Fen%2Fnewsroom%2Fhome.html&amp;esheet=53367414&amp;newsitemid=20230324005411&amp;lan=en-US&amp;anchor=Gordon+Moore+at+Intel&amp;index=1&amp;md5=e23a2ec74ee18deea343be38b8f57da2\" rel=\"nofollow noopener\" shape=\"rect\">Gordon Moore at Intel<\/a>\n<\/p>\n<p>\nDuring his lifetime, Moore also dedicated his focus and energy to philanthropy, particularly environmental conservation, science and patient care improvements. Along with his wife of 72 years, he established the Gordon and Betty Moore Foundation, which has donated more than $5.1 billion to charitable causes since its founding in 2000.\n<\/p>\n<p>\n\u201cThose of us who have met and worked with Gordon will forever be inspired by his wisdom, humility and generosity,\u201d reflected foundation president Harvey Fineberg. \u201cThough he never aspired to be a household name, Gordon\u2019s vision and his life\u2019s work enabled the phenomenal innovation and technological developments that shape our everyday lives. Yet those historic achievements are only part of his legacy. His and Betty\u2019s generosity as philanthropists will shape the world for generations to come.\u201d\n<\/p>\n<p>\nPat Gelsinger, Intel CEO, said, \u201cGordon Moore defined the technology industry through his insight and vision. He was instrumental in revealing the power of transistors, and inspired technologists and entrepreneurs across the decades. We at Intel remain inspired by Moore\u2019s Law, and intend to pursue it until the periodic table is exhausted. Gordon\u2019s vision lives on as our true north as we use the power of technology to improve the lives of every person on Earth. My career and much of my life took shape within the possibilities fueled by Gordon\u2019s leadership at the helm of Intel, and I am humbled by the honor and responsibility to carry his legacy forward.\u201d\n<\/p>\n<p>\nFrank D. Yeary, chairman of Intel\u2019s board of directors, said, \u201cGordon was a brilliant scientist and one of America\u2019s leading entrepreneurs and business leaders. It is impossible to imagine the world we live in today, with computing so essential to our lives, without the contributions of Gordon Moore. He will always be an inspiration to our Intel family and his thinking at the core of our innovation culture.\u201d\n<\/p>\n<p>\nAndy Bryant, former chairman of Intel\u2019s board of directors, said, \u201cI will remember Gordon as a brilliant scientist, a straight-talker and an astute businessperson who sought to make the world better and always do the right thing. It was a privilege to know him, and I am grateful that his legacy lives on in the culture of the company he helped to create.\u201d\n<\/p>\n<p>\nPrior to establishing Intel, Moore and Noyce participated in the founding of Fairchild Semiconductor, where they played central roles in the first commercial production of diffused silicon transistors and later the world\u2019s first commercially viable integrated circuits. The two had previously worked together under William Shockley, the co-inventor of the transistor and founder of Shockley Semiconductor, which was the first semiconductor company established in what would become Silicon Valley. Upon striking out on their own, Moore and Noyce hired future Intel CEO Andy Grove as the third employee, and the three of them built Intel into one of the world\u2019s great companies. Together they became known as the \u201cIntel Trinity,\u201d and their legacy continues today.\n<\/p>\n<p>\nIn addition to Moore\u2019s seminal role in founding two of the world\u2019s pioneering technology companies, he famously forecast in 1965 that the number of transistors on an integrated circuit would double every year \u2013 a prediction that came to be known as Moore\u2019s Law.\n<\/p>\n<p>\n\u201cAll I was trying to do was get that message across, that by putting more and more stuff on a chip we were going to make all electronics cheaper,\u201d Moore said in a 2008 interview.\n<\/p>\n<p>\nWith his 1965 prediction proven correct, in 1975 Moore revised his estimate to the doubling of transistors on an integrated circuit every two years for the next 10 years. Regardless, the idea of chip technology growing at an exponential rate, continually making electronics faster, smaller and cheaper, became the driving force behind the semiconductor industry and paved the way for the ubiquitous use of chips in millions of everyday products.\n<\/p>\n<p>\nIn 2022, Gelsinger <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.intel.com%2Fcontent%2Fwww%2Fus%2Fen%2Fnewsroom%2Fnews%2Fintel-marks-grand-opening-3b-factory-expansion-oregon.html&amp;esheet=53367414&amp;newsitemid=20230324005411&amp;lan=en-US&amp;anchor=announced+the+renaming&amp;index=2&amp;md5=cb856aedf5fd2e10b0d4fab328dee87d\" rel=\"nofollow noopener\" shape=\"rect\">announced the renaming<\/a> of the Ronler Acres campus in Oregon \u2013 where Intel teams develop future process technologies \u2013 to Gordon Moore Park at Ronler Acres. The RA4 building that\u2019s home for much of Intel\u2019s Technology Development Group was also renamed The Moore Center along with its caf\u00e9, The Gordon.\n<\/p>\n<p>\n\u201cI can think of no better way to honor Gordon and the profound impact he\u2019s had on this company than by bestowing his name on this campus,\u201d Gelsinger said at the event. \u201cI hope we did you proud today, Gordon. And the world thanks you.\u201d\n<\/p>\n<p>\nGordon Earle Moore was born in San Francisco on Jan. 3, 1929, to Walter Harold and Florence Almira \u201cMira\u201d (Williamson) Moore. Moore was educated at San Jose State University, the University of California at Berkeley, and the California Institute of Technology, where he was awarded a Ph.D. in chemistry in 1954.\n<\/p>\n<p>\nHe started his research career at the Johns Hopkins Applied Physics Laboratory in Maryland. He returned to California in 1956 to join Shockley Semiconductor. In 1957, Moore co-founded Fairchild Semiconductor, a division of Fairchild Camera and Instrument, along with Robert Noyce and six other colleagues from Shockley Semiconductor. Eleven years later, Moore and Noyce co-founded Intel.\n<\/p>\n<p>\nWith Fairchild and Intel came financial success. Beginning with individual gifts, many of them anonymous, then forming the Moore Family Foundation, and eventually, in 2000, creating the Gordon and Betty Moore Foundation, Moore and his wife sought through philanthropy to make the world a better place for future generations. His passion for impact and measurement were hallmarks of his philanthropic work and aspirations.\n<\/p>\n<p>\nHe received the National Medal of Technology from President George H.W. Bush in 1990, and the Presidential Medal of Freedom, the nation\u2019s highest civilian honor, from President George W. Bush in 2002.\n<\/p>\n<p>\nAfter retiring from Intel in 2006, Moore divided his time between California and Hawaii, serving as chairman of the board for the Gordon and Betty Moore Foundation until transitioning to chairman emeritus in 2018. Moore also served as a member of the board of directors of Conservation International and Gilead Sciences, Inc. He was a member of the National Academy of Engineering, a Fellow of the Royal Society of Engineers, and a Fellow of the Institute of Electrical and Electronics Engineers. He served as chairman of the board of trustees of the California Institute of Technology from 1995 until the beginning of 2001, and continued as a Life Trustee.\n<\/p>\n<p>\nIn 1950, Moore married Betty Irene Whitaker, who survives him. Moore is also survived by sons Kenneth and Steven and four grandchildren.\n<\/p>\n<p>\n<b>About the Gordon and Betty Moore Foundation<\/b>\n<\/p>\n<p>\nGordon and Betty Moore established the foundation to create positive outcomes for future generations. In pursuit of that vision, we foster path-breaking scientific discovery, environmental conservation, patient care improvements and preservation of the special character of the San Francisco Bay Area. Visit <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fwww.moore.org%2F&amp;esheet=53367414&amp;newsitemid=20230324005411&amp;lan=en-US&amp;anchor=Moore.org&amp;index=3&amp;md5=a41cb323b6fd0a42892a64ff1bb1ca36\" rel=\"nofollow noopener\" shape=\"rect\">Moore.org<\/a> or follow <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Ftwitter.com%2Fmoorefound&amp;esheet=53367414&amp;newsitemid=20230324005411&amp;lan=en-US&amp;anchor=%40MooreFound&amp;index=4&amp;md5=ed4a4de965dcbe4e0f8fe49bcc28bf4e\" rel=\"nofollow noopener\" shape=\"rect\">@MooreFound<\/a> on Twitter.\n<\/p>\n<p>\n<b>About Intel<\/b>\n<\/p>\n<p>\nIntel (Nasdaq: INTC) is an industry leader, creating world-changing technology that enables global progress and enriches lives. Inspired by Moore\u2019s Law, we continuously work to advance the design and manufacturing of semiconductors to help address our customers\u2019 greatest challenges. By embedding intelligence in the cloud, network, edge and every kind of computing device, we unleash the potential of data to transform business and society for the better. To learn more about Intel\u2019s innovations, go to <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=https%3A%2F%2Fnewsroom.intel.com%2F&amp;esheet=53367414&amp;newsitemid=20230324005411&amp;lan=en-US&amp;anchor=newsroom.intel.com&amp;index=5&amp;md5=ecd6a4bdf4456baf796eb389457aa54e\" rel=\"nofollow noopener\" shape=\"rect\">newsroom.intel.com<\/a> and <a target=\"_blank\" href=\"https:\/\/cts.businesswire.com\/ct\/CT?id=smartlink&amp;url=http%3A%2F%2Fintel.com%2F&amp;esheet=53367414&amp;newsitemid=20230324005411&amp;lan=en-US&amp;anchor=intel.com&amp;index=6&amp;md5=0190391c39d797f4ebbdbf6be543c4e4\" rel=\"nofollow noopener\" shape=\"rect\">intel.com<\/a>.\n<\/p>\n<p>\n\u00a9 Intel Corporation. Intel, the Intel logo and other Intel marks are trademarks of Intel Corporation or its subsidiaries. Other names and brands may be claimed as the property of others.\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nWill Moss<br \/>\n<br \/>Intel Corporation<br \/>\n<br \/>1-650-521-1754<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;i&#x6c;t&#111;&#x3a;&#119;&#x69;l&#108;&#x69;&#97;&#x6d;&#46;&#x6d;&#x6f;&#115;&#x73;&#64;&#x69;n&#116;&#x65;&#108;&#x2e;c&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">&#x77;&#105;l&#x6c;&#105;a&#x6d;&#46;m&#x6f;&#115;s&#x40;&#105;n&#x74;&#101;l&#x2e;&#99;o&#x6d;<\/a>\n<\/p>\n<p>\nGenny Biggs<br \/>\n<br \/>Gordon and Betty Moore Foundation<br \/>\n<br \/>1-415-577-0094<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#97;i&#x6c;&#x74;&#111;:&#x47;&#x65;&#110;n&#x79;&#x2e;&#66;i&#x67;&#x67;&#115;&#64;&#x6d;&#111;&#111;r&#x65;&#46;o&#x72;&#x67;\" rel=\"nofollow noopener\" shape=\"rect\">&#x47;e&#x6e;&#110;&#x79;&#46;&#x42;&#x69;g&#x67;&#115;&#x40;&#109;&#x6f;&#111;r&#x65;&#46;&#x6f;&#114;&#x67;<\/a>\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Moore, who set the course for the future of the semiconductor industry, devoted his later years to philanthropy. SANTA CLARA, Calif.&#8211;(BUSINESS WIRE)&#8211;Intel and the Gordon and Betty Moore Foundation announced today that company co-founder Gordon Moore has passed away at the age of 94. The foundation reported he died peacefully on Friday, March 24, 2023, &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/gordon-moore-intel-co-founder-dies-at-94\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-55186","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Gordon Moore, Intel Co-Founder, Dies at 94 - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/gordon-moore-intel-co-founder-dies-at-94\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Gordon Moore, Intel Co-Founder, Dies at 94 - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"Moore, who set the course for the future of the semiconductor industry, devoted his later years to philanthropy. SANTA CLARA, Calif.&#8211;(BUSINESS WIRE)&#8211;Intel and the Gordon and Betty Moore Foundation announced today that company co-founder Gordon Moore has passed away at the age of 94. The foundation reported he died peacefully on Friday, March 24, 2023, ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/gordon-moore-intel-co-founder-dies-at-94\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-03-25T00:03:16+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230324005411\/en\/1747445\/21\/gordon-moore-6-rwd.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"7 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gordon-moore-intel-co-founder-dies-at-94\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gordon-moore-intel-co-founder-dies-at-94\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Gordon Moore, Intel Co-Founder, Dies at 94\",\"datePublished\":\"2023-03-25T00:03:16+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gordon-moore-intel-co-founder-dies-at-94\\\/\"},\"wordCount\":1387,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gordon-moore-intel-co-founder-dies-at-94\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230324005411\\\/en\\\/1747445\\\/21\\\/gordon-moore-6-rwd.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gordon-moore-intel-co-founder-dies-at-94\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gordon-moore-intel-co-founder-dies-at-94\\\/\",\"name\":\"Gordon Moore, Intel Co-Founder, Dies at 94 - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gordon-moore-intel-co-founder-dies-at-94\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gordon-moore-intel-co-founder-dies-at-94\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230324005411\\\/en\\\/1747445\\\/21\\\/gordon-moore-6-rwd.jpg\",\"datePublished\":\"2023-03-25T00:03:16+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gordon-moore-intel-co-founder-dies-at-94\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gordon-moore-intel-co-founder-dies-at-94\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gordon-moore-intel-co-founder-dies-at-94\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230324005411\\\/en\\\/1747445\\\/21\\\/gordon-moore-6-rwd.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230324005411\\\/en\\\/1747445\\\/21\\\/gordon-moore-6-rwd.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/gordon-moore-intel-co-founder-dies-at-94\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Gordon Moore, Intel Co-Founder, Dies at 94\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Gordon Moore, Intel Co-Founder, Dies at 94 - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/gordon-moore-intel-co-founder-dies-at-94\/","og_locale":"en_US","og_type":"article","og_title":"Gordon Moore, Intel Co-Founder, Dies at 94 - Pharma Trend","og_description":"Moore, who set the course for the future of the semiconductor industry, devoted his later years to philanthropy. SANTA CLARA, Calif.&#8211;(BUSINESS WIRE)&#8211;Intel and the Gordon and Betty Moore Foundation announced today that company co-founder Gordon Moore has passed away at the age of 94. The foundation reported he died peacefully on Friday, March 24, 2023, ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/gordon-moore-intel-co-founder-dies-at-94\/","og_site_name":"Pharma Trend","article_published_time":"2023-03-25T00:03:16+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230324005411\/en\/1747445\/21\/gordon-moore-6-rwd.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"7 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/gordon-moore-intel-co-founder-dies-at-94\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/gordon-moore-intel-co-founder-dies-at-94\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Gordon Moore, Intel Co-Founder, Dies at 94","datePublished":"2023-03-25T00:03:16+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/gordon-moore-intel-co-founder-dies-at-94\/"},"wordCount":1387,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/gordon-moore-intel-co-founder-dies-at-94\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230324005411\/en\/1747445\/21\/gordon-moore-6-rwd.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/gordon-moore-intel-co-founder-dies-at-94\/","url":"https:\/\/pharma-trend.com\/en\/gordon-moore-intel-co-founder-dies-at-94\/","name":"Gordon Moore, Intel Co-Founder, Dies at 94 - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/gordon-moore-intel-co-founder-dies-at-94\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/gordon-moore-intel-co-founder-dies-at-94\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230324005411\/en\/1747445\/21\/gordon-moore-6-rwd.jpg","datePublished":"2023-03-25T00:03:16+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/gordon-moore-intel-co-founder-dies-at-94\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/gordon-moore-intel-co-founder-dies-at-94\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/gordon-moore-intel-co-founder-dies-at-94\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230324005411\/en\/1747445\/21\/gordon-moore-6-rwd.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230324005411\/en\/1747445\/21\/gordon-moore-6-rwd.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/gordon-moore-intel-co-founder-dies-at-94\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Gordon Moore, Intel Co-Founder, Dies at 94"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55186","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=55186"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/55186\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=55186"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=55186"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=55186"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}